- Home
- AVTR vs KYMR Comparison
AVTR vs KYMR Comparison
Compare AVTR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTR | KYMR |
|---|---|---|
| Founded | 1904 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.6B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AVTR | KYMR |
|---|---|---|
| Price | $15.03 | $110.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 23 |
| Target Price | $14.66 | ★ $138.64 |
| AVG Volume (30 Days) | ★ 7.9M | 583.7K |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $6,552,200,000.00 | $39,211,000.00 |
| Revenue This Year | $0.63 | $167.86 |
| Revenue Next Year | $2.36 | N/A |
| P/E Ratio | $254.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.27 | $55.26 |
| 52 Week High | $16.05 | $130.05 |
Technical Indicators
Market Signals| Indicator | AVTR | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 46.65 |
| Support Level | $13.20 | $110.64 |
| Resistance Level | $16.05 | $121.24 |
| Average True Range (ATR) | 0.44 | 4.38 |
| MACD | -0.10 | -0.72 |
| Stochastic Oscillator | 35.47 | 32.29 |
Price Performance
Historical ComparisonAbout AVTR Avantor Inc.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.